Navigation Links
Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts

HAMBURG, Germany, December 11 /PRNewswire/ -- Olympus has further cemented its position as a leader in the field of minimally invasive surgery by signing an exclusive and immediate deal to distribute the products of Irish company Advanced Surgical Concepts worldwide. ASC is the sole global provider of ports for state-of-the-art laparoscopic operative techniques via a single access point - the patient's navel. Olympus is now the exclusive distributor for the full range of products involved.

Laparo Endoscopic Single-site Surgery (LESS surgery) - endoscopic surgery via the umbilicus - ranks as one of the most important recent innovations in medical technology. As distributor for the TriPorts and QuadPorts developed by ASC, Olympus is now a key player in the technology of this high-potential market. Using these ports, three or four instruments can be introduced into the patient's abdomen via a single access point (e.g. the navel). Up to now, most minimally invasive operations required three or even four separate access points.

"As the global market leader in the field of quality endoscopic systems, we will now be supplying the ports, the manual instruments and the optics for the dynamic field of minimally invasive surgery from a single source," explains Heinz Jacqui, CEO at Olympus Winter & Ibe, referring to the strategic distribution partnership. In addition to its responsibilities in the area of sales cooperation, this subsidiary company also runs Olympus' surgical development and production centre.

"By using the cooperation with Olympus and their worldwide distribution network we are able to offer our products in combination with today's best endoscopic system," says Frank Bonadio, CEO of Advanced Surgical Concepts Limited. "The synergy between our companies' products will allow us to dominate the market for LESS surgery and results in the long term cooperation of our two companies."

The market for minimally invasive products is constantly expanding. In Europe alone, around 900,000 gall bladder operations are carried out each year. Over the next few years, a larger number of gall bladder operations will be performed via the umbilicus. Experts predict a significant increase in operations - including complex operations - involving 'scarless' surgery within the coming years.

In addition to the benefits for the patient in terms of the cosmetic aspect and reduction in pain from the healing process, this new form of access brings advantages for hospitals, with costs being held at the same level as for conventional operating techniques, whilst continuing the trend towards shorter in-patient times and reduced hospital costs through minimised risk of post-operative infection.

With its products and systems solutions, Olympus is positioning itself as a capable partner for the medical sector. Flexible and rigid endoscopes are playing a decisive role in minimally invasive diagnostics and therapy. The company's range of products comprises endoscopes and systems solutions for wide-ranging applications in internal medicine and surgery, endoscopic video systems, reprocessing systems and a broad selection of endotherapy products.

    For further information, please contact:
    Silvia Schanze
    Corporate Marketing
    Olympus Winter & Ibe GmbH
    Kuhnstrasse 61, 22045 Hamburg
    Tel: +49-40-669-66-2370

SOURCE Olympus Winter & Ibe
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
2. Minimally Invasive Treatment Offers Hope for Liver Cancer Patients
3. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
4. Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
5. New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases
6. Noninvasive Medical Technologies Helps Make Young Tennessee Womans Wishes Come True
7. Non-Invasive Radiosurgery with Novalis Tx(TM) Platform Rolling Out Worldwide
8. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
9. Carnegie Mellon MRI technology that noninvasively locates, quantifies specific cells in the body
10. BugLab Launches Noninvasive Biomass Monitor for Continuous, On-Line Measurements
11. Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... England , November 26, 2015 ... medical device company specializing in imaging technologies, announced today that ... Commission as part of the Horizon 2020 European Union Framework ... out a large-scale clinical trial in breast cancer. ... , --> --> ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
Breaking Biology News(10 mins):